Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinical Trial Not Allowed)
ID: 352347Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352347

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-24-003.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Feb 14, 2024 12:00 AM
  4. 4
    Due Apr 17, 2024 12:00 AM
Description

The National Institutes of Health (NIH) has posted a grant opportunity titled "Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinical Trial Not Allowed)". This opportunity falls under the category of Health and is a discretionary grant. The funding instrument type for this opportunity is a Cooperative Agreement. The CFDA number associated with this grant is 93.307.

The purpose of this grant is to identify genetic variants that affect the susceptibility to develop alcohol use disorder (AUD). The grant aims to advance the understanding of the complexity of the genotypes and phenotypes that contribute to the heterogeneity of AUD. It also seeks to integrate the analysis of multiple data sources and generate mechanistic hypotheses to understand the contributions of genetic, behavioral, and environmental factors on the development of or resilience from AUD.

This limited competition notice of funding opportunity (NOFO) is specifically soliciting a cooperative agreement (U10) application from investigators who are currently supported under an existing study called Collaborative Study on the Genetics of Alcoholism (COGA). The grant does not require cost sharing or matching.

Small businesses and other eligible applicants are invited to apply. However, non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are also not allowed.

The deadline for submitting applications is April 17, 2024. For more information and to apply, please visit the following link: http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-24-003.html. If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
RFA-AA-24-003-Full-Announcement.html
4/10/2024
Similar Opportunities
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)". This grant is in the category of Health and falls under the funding instrument type of Grant. The purpose of this grant is to support an integrated, broad-based multidisciplinary, multi-investigator, long-term program of research and research support activities planned around a specific major research theme related to alcohol research. The grant does not require any cost sharing or matching requirement. The maximum award ceiling for this grant is $1,250,000. The eligibility for this grant is open to various types of applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, Non-domestic (non-U.S.) Entities (Foreign Organization) and non-U.S. components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. The closing date for this grant opportunity is November 15, 2024, and the archive date is December 21, 2024. For more information and to apply, please visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-24-008.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-24-008.html). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)". This grant aims to support Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that propose the development of therapeutic agents for the treatment of alcohol use disorder (AUD) and/or alcohol-associated organ damage (AAOD). The grant seeks eligible applicants who have identified a therapeutic candidate with a robust body of background data in the basic science and early discovery phases, ready for transition to the preclinical and clinical phases of development. The candidate should possess favorable properties such as bioactivity, stability, manufacturability, bioavailability, in vivo efficacy, and target engagement consistent with the desired clinical application. Projects responsive to this announcement can be at any point along the drug development continuum, from late discovery to early-stage clinical trials. For small molecules, eligibility requires having small-molecule compounds with proof of desired pharmacological activity. For biologics, the profiling of promising product candidates in animal models of AUD or AAOD is allowed as the earliest entry point. The ultimate goal of this grant is to advance molecules closer to U.S. Food and Drug Administration (FDA) approval. Milestones will be tailored to the proposed project. While early-phase clinical trials are supported, they are not mandatory. Small disadvantaged and women-owned small businesses are encouraged to apply. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-102.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-102.html). If you have any inquiries, please contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)". This grant aims to address the treatment gap for individuals with alcohol use disorder (AUD) by focusing on five major areas of emphasis. These areas include increasing access to treatment for AUD, making treatment more appealing, examining cost structures and insurance systems, conducting studies on dissemination and implementation of evidence-based approaches, and reducing health disparities for health disparity populations. The grant has a funding ceiling of $450,000 and does not require cost sharing or matching. The deadline for applications is September 7, 2026. For more information and to apply, visit the following link: [Alcohol Treatment, Pharmacotherapy, and Recovery Research Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-249.html).
Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health is offering an Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed) grant. This grant aims to support investigator-initiated resources that provide materials and services to advance biomedical research on a national level. The resources should be designed to serve the broad alcohol research community and should not be limited by any specific regional focus. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs). Non-domestic (non-U.S.) entities and components are not eligible to apply. The grant opportunity will close on September 25, 2026, and the archive date is October 31, 2026. For more information and to apply, visit the following link: [Alcohol Research-Related Resource Award Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-24-071.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)". This grant aims to support research focused on alcohol treatment and recovery. The grant will cover a broad range of topics related to the treatment and recovery from alcohol use disorder (AUD), including medications development, precision medicine, behavioral therapies, mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery. The grant does not require cost sharing or matching. The maximum award ceiling is $500,000. The deadline for applications is September 7, 2026. For more information and to apply, visit the following link: [Alcohol Treatment, Pharmacotherapy, and Recovery Research Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-250.html).